Uploaded June 2025 | Updated September 2026, 3 weeks ago
0:00 - Intro
0:35 - Arrow Electronics Joins the Council
2:09 - 21 Shares ETP
14:08 - Gregg Bell on Hedgeye
17:26 - ETFs Impact on ALT SZN
18:50 - Hedera Scam Warning from the FBI
21:49 - Shout Out to Pineapple.HBAR and Davinci Graph
22:36 - Milan and Michael Kantor win Hiero Seats
35:18 - Mauii's NFT Analytics
35:43 - Hsuite Developer Portal
36:10 - Earthlings Main Game Avatars
36:25 - Sporting Crypto Conference
37:35 - Shark Bites
55:40 - Network Analysis and the HBAR Market
The following is not investment advice and should be used for educational or entertainment purposes only. Consult a financial advisor before making any investment decision. You should not treat any opinion expressed as a specific inducement to make a particular investment or follow a particular strategy. Though opinions expressed are based on information that participants may consider reliable, that information can be incorrect or incomplete. Past performance is not indicative of future results. Coverage should not be considered an endorsement. DYOR
0:00 - Intro
0:35 - Arrow Electronics Joins the Council
2:09 - 21 Shares ETP
14:08 - Gregg Bell on Hedgeye
17:26 - ETFs Impact on ALT SZN
18:50 - Hedera Scam Warning from the FBI
21:49 - Shout Out to Pineapple.HBAR and Davinci Graph
22:36 - Milan and Michael Kantor win Hiero Seats
35:18 - Mauii's NFT Analytics
35:43 - Hsuite Developer Portal
36:10 - Earthlings Main Game Avatars
36:25 - Sporting Crypto Conference
37:35 - Shark Bites
55:40 - Network Analysis and the HBAR Market
The following is not investment advice and should be used for educational or entertainment purposes only. Consult a financial advisor before making any investment decision. You should not treat any opinion expressed as a specific inducement to make a particular investment or follow a particular strategy. Though opinions expressed are based on information that participants may consider reliable, that information can be incorrect or incomplete. Past performance is not indicative of future results. Coverage should not be considered an endorsement. DYOR










